Access to and use of preventive intermittent treatment for Malaria during pregnancy: A qualitative study in the Chókwè district, Southern Mozambique.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 22 08 2018
accepted: 08 01 2019
entrez: 25 1 2019
pubmed: 25 1 2019
medline: 29 9 2019
Statut: epublish

Résumé

Malaria remains a significant health problem in Mozambique, particularly in the case of pregnant women and children less than five years old. Intermittent preventive treatment with sulfadoxine-pyrimethamine (IPT-SP) is recommended for preventing malaria in pregnancy (MiP). Despite the widespread use and cost-effectiveness of IPTp-SP, coverage remains low. In this study, we explored factors limiting access to and use of IPTp-SP in a rural part of Mozambique. We performed a qualitative study using semi-structured interviews to collect data from 46 pregnant women and four health workers in Chókwè, a rural area of southern Mozambique. Data were transcribed, translated where appropriate, manually coded, and the content analyzed according to key themes. The women interviewed were not aware of the risks of MiP or the benefits of its prevention. Delays in accessing antenatal care, irregular attendance of visits, and insufficient time for proper antenatal care counselling by health workers were driving factors for inadequate IPTp delivery. Pregnant women face substantial barriers in terms of optimal IPTp-SP uptake. Health system barriers and poor awareness of the risks and consequences of MiP and of the measures available for its prevention were identified as the main factors influencing access to and use of IPTp-SP. Implementation of MiP prevention strategies must be improved through intensive community health education and increased access to other sources of information. Better communication between health workers and ANC clients and better knowledge of national ANC and IPTp policies are important.

Sections du résumé

BACKGROUND
Malaria remains a significant health problem in Mozambique, particularly in the case of pregnant women and children less than five years old. Intermittent preventive treatment with sulfadoxine-pyrimethamine (IPT-SP) is recommended for preventing malaria in pregnancy (MiP). Despite the widespread use and cost-effectiveness of IPTp-SP, coverage remains low. In this study, we explored factors limiting access to and use of IPTp-SP in a rural part of Mozambique.
METHODS AND FINDINGS
We performed a qualitative study using semi-structured interviews to collect data from 46 pregnant women and four health workers in Chókwè, a rural area of southern Mozambique. Data were transcribed, translated where appropriate, manually coded, and the content analyzed according to key themes. The women interviewed were not aware of the risks of MiP or the benefits of its prevention. Delays in accessing antenatal care, irregular attendance of visits, and insufficient time for proper antenatal care counselling by health workers were driving factors for inadequate IPTp delivery.
CONCLUSIONS
Pregnant women face substantial barriers in terms of optimal IPTp-SP uptake. Health system barriers and poor awareness of the risks and consequences of MiP and of the measures available for its prevention were identified as the main factors influencing access to and use of IPTp-SP. Implementation of MiP prevention strategies must be improved through intensive community health education and increased access to other sources of information. Better communication between health workers and ANC clients and better knowledge of national ANC and IPTp policies are important.

Identifiants

pubmed: 30677039
doi: 10.1371/journal.pone.0203740
pii: PONE-D-18-24709
pmc: PMC6345468
doi:

Substances chimiques

Antimalarials 0
Drug Combinations 0
fanasil, pyrimethamine drug combination 37338-39-9
Sulfadoxine 88463U4SM5
Pyrimethamine Z3614QOX8W

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0203740

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Malar J. 2009 Feb 12;8:25
pubmed: 19216759
PLoS Med. 2013;10(7):e1001488
pubmed: 23935459
BMC Pregnancy Childbirth. 2015 Feb 13;15:26
pubmed: 25886593
PLoS One. 2010 Nov 29;5(11):e15066
pubmed: 21124732
Reprod Health. 2011 Jan 28;8:3
pubmed: 21276252
Malar J. 2018 Mar 12;17(1):109
pubmed: 29530044
Malar J. 2016 Nov 4;15(1):530
pubmed: 27809918
PLoS One. 2014 Feb 03;9(2):e86038
pubmed: 24498268
Malar J. 2010 Feb 17;9:54
pubmed: 20163707
Health Policy. 2007 May;81(2-3):228-41
pubmed: 16876286
Malar J. 2012 Sep 07;11:317
pubmed: 22958539
Clin Infect Dis. 2016 Feb 1;62(3):323-333
pubmed: 26486699
Lancet Infect Dis. 2011 Mar;11(3):190-207
pubmed: 21273130
PLoS One. 2013;8(1):e53747
pubmed: 23335973
Reprod Health. 2016 Jun 08;13 Suppl 1:31
pubmed: 27356968
PLoS Med. 2010 Jan 26;7(1):e1000221
pubmed: 20126256
PLoS One. 2011;6(7):e22452
pubmed: 21799859
PLoS One. 2016 Aug 05;11(8):e0160008
pubmed: 27494250
PLoS One. 2010 Feb 26;5(2):e9438
pubmed: 20195472
Pan Afr Med J. 2016 Oct 01;25(Suppl 1):4
pubmed: 28149434
Malar J. 2015 Dec 23;14:521
pubmed: 26701641

Auteurs

Paulo Arnaldo (P)

Plataforma de Parasitologia Molecular, Instituto Nacional de Saúde, Maputo, Mozambique.
Department of Biomedical Sciences, Institute of Tropical Medicine Antwerp, Antwerp, Belgium.
Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.

Maria Isabel Cambe (MI)

Programa de Sistemas de Saúde, Instituto Nacional de Saúde, Maputo, Mozambique.

Amílcar Magaço (A)

Programa de Sistemas de Saúde, Instituto Nacional de Saúde, Maputo, Mozambique.

Sérgio Chicumbe (S)

Programa de Sistemas de Saúde, Instituto Nacional de Saúde, Maputo, Mozambique.

Eduard Rovira-Vallbona (E)

Department of Biomedical Sciences, Institute of Tropical Medicine Antwerp, Antwerp, Belgium.

Anna Rosanas-Urgell (A)

Department of Biomedical Sciences, Institute of Tropical Medicine Antwerp, Antwerp, Belgium.

Sónia M Enosse (SM)

Plataforma de Parasitologia Molecular, Instituto Nacional de Saúde, Maputo, Mozambique.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH